SPOTLIGHT: Law & Order
Martha Stewart, the celebrity design diva synonymous with domestic perfection,
was sentenced Friday to five months in prison, five months of home confinement
and handed a $30,000 (U.S.) fine for lying to U.S. authorities about a stock
sale. Read Roma Lucic's full report.
Questions of Insider Trading
Raised in OSC Probe
OSC Cracks Down on RESP Sector
The Ontario Securities Commission has blocked two of the leading players in
Canada's burgeoning education savings plan sector from taking on new business
and put a host of restrictions on others in a crackdown on an industry it says
is rife with problems. Read the latest from Karen Howlett and Paul Waldie.
Costello Loses Appeal of OSC Ruling
High profile personal finance commentator Brian Costello has lost his appeal of
an Ontario Securities Commission decision that found he gave investment advice
at seminars without proper registration. Read the full report.
FINANCIAL PLANNING: Special Needs,
Financial plans tough to make for family with special-needs kids
Family life in a small Ontario city ought to be affordable on a combined gross
income of $87,000 a year. But what if your children have special and very
costly medical needs that are only partially covered by provincial programs?
Andrew Allentuck reports.
little justification for balance insurance
The only reason for taking out credit card balance insurance is to bolster
bank profits. There's simply no other justification for insuring the unpaid
balance on your credit card against, say, death or serious illness. Rob
Martin's Cabinet, To Risk or Not To Risk?
and... The Goat
Bay Street's Pick: Goodale by a Nose
Bay Street is playing it coy because there's so much at stake, but many in the
financial community want Ralph Goodale to remain Finance Minister when Paul
Martin names his new cabinet next week. Failing that, they'd opt for Anne
McLellan in the post. Read Andrew Willis's Streetwise insight.
Mutual Investors Shun Equities for More Conservative Products
Investors continued to shun equity funds last month, opting to put the bulk of
$491-million in new investment into conservative income, bond and balanced
funds, the mutual fund industry reported yesterday. Read Keith Damsell's report.
Asia Funds Seen as Hot Performers
ConjuChem: Investing in Biotech a Risky Business
The vagaries of investing in biotech were never more obvious than after drug
developer ConjuChem Inc. posted mixed clinical test results for a highly touted
diabetes treatment, igniting a selling frenzy that halved the stock price
yesterday. Read Leonard Zehr's report.
Enter The Goat
The Globe and Mail's premiere business gossip columnist (sorry, investigative
journalist!) is now available on globeadvisor.com. Chewing his way through the
high and mighty, The Goat digs out the human story behind the headlines three
times a week. Catch his latest column today!